10 YEAR RETROSPECTIVE COHORT ANALYSIS OF INFLAMMATORY BOWEL DISEASE IN A SPECIALIZED CLINIC OF BRAZIL

Authors

  • Jéssica Martins Torres Escola Superior de Ciências da Santa Casa de Misericórdia de Vitória (EMESCAM). Curso de Medicina. Vitória – ES - Brasil
  • Gabriela Escola Superior de Ciências da Santa Casa de Misericórdia de Vitória (EMESCAM). Curso de Medicina. Vitória – ES - Brasil
  • Felipe Escola Superior de Ciências da Santa Casa de Misericórdia de Vitória (EMESCAM). Curso de Medicina. Vitória – ES - Brasil
  • Ana Paula Hamer Sousa Clara Escola Superior de Ciências da Santa Casa de Misericórdia de Vitória (EMESCAM). Curso de Medicina. Vitória – ES - Brasil
  • Felipe Welling Lorentz Escola Superior de Ciências da Santa Casa de Misericórdia de Vitória (EMESCAM). Curso de Medicina. Vitória – ES - Brasil
  • Fabiano Quarto Martins Escola Superior de Ciências da Santa Casa de Misericórdia de Vitória (EMESCAM). Curso de Medicina. Vitória – ES - Brasil

DOI:

https://doi.org/10.26432/1809-3019.2021.66.034

Keywords:

Crohn Disease, Colitis Ulcerative, Epidemiology

Abstract

Introduction: Inflammatory bowel disease it’s an idiopathic disorder that leads to inflammation of the gastroenteric tissue. The two main representatitves of this condition are Crohn’s Disease and Ulcerative Colitis. The increasing incidence of this disorder in developing countries such as Brazil makes the understanding of epidemiological aspects increasingly important. Objective: This article aimed to explore the clinical-epidemiological aspects of patients diagnosed with inflammatory bowel disease. Method: It’s a retrospective cohort study. The study design includes the patients diagnosed with inflammatory bowel disease seen at the gastroenterology clinic of the Hospital Santa Casa de Misericórdia de Vitória during January,2010 to Deczember 2019. Results: The average age at the time of the diagnosis was 35,1 years old. The analysis shows that 67,5% of the patients with Crohn’s Disease (CD) was hospitalized at least one time due to descompensation compared to 19% of Ulcerative Colitis (UC) patients.  24,7% of the UC participants made use of  immunobiological therapy contrasted with 63,2% of CD patients. Conclusion: This article brings to light new epidemiological data and disease’s behavior regarding inflammatory bowel disease in the state of Espírito Santo besides uncovers important divergences between this study and other articles. This way, it becomes an important tool to the Gastroenterology clinic.

Downloads

Download data is not yet available.

Published

2021-10-29

Issue

Section

ARTIGO ORIGINAL